Irinotecan Kabi 20 mg/ml concentrate for solution for infusion

Land: Bulgarien

Sprache: Bulgarisch

Quelle: Изпълнителна агенция по лекарствата

Wirkstoff:

Иринотекан

Verfügbar ab:

Fresenius Kabi Oncology Plc.

ATC-Code:

L01XX19

INN (Internationale Bezeichnung):

Irinotecan

Dosierung:

20 mg/ml concentrate for solution for infusion

Produktbesonderheiten:

Irinotecan Kabi, 20 mg/ml concentrate for solution for infusion - 2 ml x 1;2 ml x 5; 5 ml x 1; 5 ml x 5

Berechtigungsdatum:

2013-12-18